ICB International

The Company has developed breakthrough technology comprising of antibody mimics, referred to as SMART Molecules (SMs), to overcome the hurdles of the blood-brain barrier (BBB). The BBB is a physical barrier that protects the brain from the blood-born pathogenic. The BBB does not allow the access of nearly 98% of all pharmaceuticals to the central nervous system (CNS), which is one of the main reasons why there are no curative treatments for most of the CNS diseases. The good news is that ICBII has solved this insurmountable problem.